Ageing is a progressive reduction in physiological integrity, resulting in functional deterioration and increased vulnerability to mortality. Research into ageing has discovered that genetic pathways and biochemical processes play a significant role in regulating the pace of ageing.
They have been summarized as the twelve hallmarks of ageing. Tackling most of these hallmarks makes MonaJuventa™ Nu the first botanical capable of turning back the aging clock.
Discover the power of healthy aging with MonaJuventa Nu, the key to a longer, healthier life. Promoting longevity provides several advantages, including prolonging lifespan, delaying the onset of age-related diseases, and improving quality of life.
MonaJuventa Nu can be considered the next ingredient generation in the field of healthy ageing and rejuvenation. It impressively addresses eight out of twelve ageing hallmarks, thereby contributing to the slowdown of ageing processes.
Striking results on cellular longevity have been demonstrated not only in various cellular tests but also in a placebo-controlled human study. MonaJuventa Nu has proven to reduce epigenetic ageing, decrease telomere attrition, improve mitochondrial dysfunction, boost ATP production and lower the numbers of senescent cells — just to name a few.
Supplementation of 100 mg MonaJuventa Nu daily allows for the deceleration of epigenetic ageing at a rate equivalent to nearly two years compared to the placebo group just after three months of supplementation.
This is a real breakthrough in the longevity space. Beyond this benefit, MonaJuventa Nu remarkably slows down the rate of telomere shortening, effectively combating cellular ageing and promoting cellular vitality.
MonaJuventa Nu is made from scarlet beebalm (Monarda didyma), a plant rich in the bioflavonoid didymin and known for improving mitochondrial function. The product has a pleasant herbal taste and demonstrates good solubility, enabling the development of a wide range of supplement formats.
Click here to learn more about MonaJuventa™ Nu.
